Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease

Serum PCT is independently and positively associated with SXs. Thus, elevated PCT levels may be useful to identify patients with high coronary atherosclerotic burden in patients with stable CAD.